Results 341 to 350 of about 677,906 (386)
Some of the next articles are maybe not open access.

Erlotinib hydrochloride

Nature Reviews Drug Discovery, 2005
Erlotinib hydrochloride (Tarceva; OSI Pharmaceuticals/Genentech/Roche), a member of a class of targeted anticancer drugs that inhibit the activity of the epidermal growth factor receptor, was approved by the US FDA in November 2004 for the treatment of advanced non-small-cell lung cancer after failure of at least one prior chemotherapy regimen.
Jonathan Dowell   +2 more
openaire   +2 more sources

Colesevelam hydrochloride

American Journal of Health-System Pharmacy, 2002
The pharmacology, pharmacodynamics, clinical efficacy, drug interactions, adverse effects, and dosage and administration of colesevelam hydrochloride are reviewed. Colesevelam hydrochloride is a nonabsorbed lipid-lowering agent approved for use alone or in combination with hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors for the ...
openaire   +2 more sources

Protopine hydrochloride

Acta Crystallographica Section C Crystal Structure Communications, 2001
Protopine hydrochloride (5,6,14,14a-tetrahydro-14a-hydroxy-7-methyl-8H-bis[1,3]benzodioxolo[5,6-a:4,5-g]quinolizinium chloride, C20H20NO5(+)-Cl(-)) is the salt of the isoquinoline alkaloid protopine. It is formed by the action of dilute hydrochloric acid on the protopine free base.
J, Dostál   +4 more
openaire   +2 more sources

Clonidine Hydrochloride

Southern Medical Journal, 1982
Clonidine hydrochloride (Catapres), a potent antihypertensive agent, has been in clinical use since 1974 in the United States. Clonidine, an alpha-adrenergic receptor agonist, stimulates central alpha receptors in the depressor site of the vasomotor center of the medulla oblongata and hypothalamus, which diminishes efferent sympathetic tone to the ...
openaire   +2 more sources

Raloxifene hydrochloride

American Journal of Health-System Pharmacy, 2000
The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and therapeutic role of raloxifene hydrochloride are reviewed. Raloxifene is a selective estrogen-receptor modulator (SERM) that has been approved for use in the prevention and treatment of osteoporosis in postmenopausal women.
K R, Snyder, N, Sparano, J M, Malinowski
openaire   +2 more sources

Flurazepam hydrochloride

Clinical Pharmacology & Therapeutics, 1975
Flurazepam (Dalmane, Ro 5‐6901) was introduced in 1970 in the United States as an hypnotic. Its popularity has increased rapidly. In 1973 more than 6.5 million prescriptions for flurazepam were filled at American retail pharmacies, at a total expenditure exceeding 8 million dollars.
D J, Greenblatt   +2 more
openaire   +2 more sources

Paroxetine Hydrochloride

2013
Paroxetine hydrochloride (3S-trans)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-piperidine hydrochloride (or (-)-(3S,4R)-(4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)-phenoxy]methyl]piperidine hydrochloride), a phenylpiperidine derivative, is a selective serotonin reuptake inhibitor.
David, Germann   +3 more
openaire   +2 more sources

Ticlopidine Hydrochloride

Journal of Neuroscience Nursing, 1992
Ticlopidine, a new prototype antiplatelet agent, offers a significant alternative in the primary and secondary prevention of atherothrombotic stroke. While 2 multicenter trials demonstrated benefits of ticlopidine, this drug is not without risks and limitations and more studies are indicated.
openaire   +2 more sources

Carcinogenicity of methapyrilene hydrochloride, mepyramine hydrochloride, thenyldiamine hydrochloride, and pyribenzamine hydrochloride in Sprague-Dawley rats

Journal of Cancer Research and Clinical Oncology, 1986
Four histamine antagonists, methapyrilene, thenyldiamine, mepyramine and pyribenzamine were tested for carcinogenicity in rats by continuous application in drinking water. Only methapyrilene displayed significant carcinogenic effects, inducing liver tumors in a dose-related pattern.
M, Habs, P, Shubik, G, Eisenbrand
openaire   +2 more sources

Bupropion Hydrochloride

2016
Bupropion hydrochloride is a norepinephrine-dopamine disinhibitor (NDDI) approved for the treatment of depression and smoking cessation. Bupropion is a trimethylated monocyclic phenylaminoketone second-generation antidepressant, which differs structurally from most antidepressants, and resides in a novel mechanistic class that has no direct action on ...
S R, Khan   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy